Pitavastatin Impurity 130 CAS CATO-C4X-1037130
| CAS No. | CATO-C4X-1037130 |
| Molecular Formula | C29H32FNO4 |
| Molecular Weight | 477.57 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Pitavastatin Impurity 130 is closely related to a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Pitavastatin Impurity 130 (CAS CATO-C4X-1037130), a pharmacopoeial impurity reference standard (molecular formula C29H32FNO4, MW 477.57 g/mol) used for the identification and quantification of trace impurities in APIs.
Structurally, Pitavastatin Impurity 130 (C29H32FNO4) contains a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. The molecule exhibits a degree of unsaturation (DBE) of 14.0, corresponding to approximately 14 ring(s) or double-bond equivalent(s). With a molecular weight of 477.57 g/mol, it falls into the moderately-high-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Pitavastatin Impurity 130 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C29H32FNO4 |
| Molecular Weight | 477.57 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | 95% |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 14.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 1 |
Related Pitavastatin Standards
- Pitavastatin Impurity 12 (CAS 586966-54-3)
- Pitavastatin Impurity 66 (CAS CATO-C4X-103766)
- Pitavastatin Impurity 67 (CAS 586966-55-4)
- Pitavastatin Impurity 68 (CAS 1258947-29-3)
- Pitavastatin Impurity 70 (CAS CATO-C4X-103770)
- Pitavastatin Impurity 71 (CAS CATO-C4X-103771)
- Pitavastatin Impurity 72 (CAS CATO-C4X-103772)
- Pitavastatin Impurity 107 (CAS CATO-C4X-1037107)
Recommended Standards
- AZD-1390 (CAS 2089288-03-7)
- Ritanserin (CAS 87051-43-2)
- rel-(3R,5S,E)-tert-Butyl 7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate (CAS 615263-53-1)
- Fmoc-HoCys(Mob)-OH (CAS 2044710-98-5)
- Lornoxicam Impurity 20 (CAS 54166-60-8)
- Fluticasone Furoate Impurity 2 (CAS 1355648-15-5)
- Pioglitazone impurity 53 (CAS CATO-C4X-138353)
- 2,5-Dichloro-4-(methylthio)pyrimidine (CAS 1245830-98-1)
- 6-Bromo-5-nitropyridin-2-amine (CAS 84487-05-8)
- Isopropylthiobenzene (CAS 3019-20-3)
- 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile (CAS 1207836-10-9)
- 8-Bromo-1-ethyl-2-fluoronaphthalene (CAS 2792709-80-7)
- (2-Amino-4-chlorophenyl)(4-methylpiperazin-1-yl)methanone (CAS 926202-02-0)
- Myristoyl Pentapeptide-4 (CAS 1392416-25-9)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com